![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1467, 2004-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quadrivalent HPV vaccine immunogenic, safe
Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HPV vaccine protects against cervical cancer precursors
Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HPV vaccine recombinant quadrivalent: safety concerns
Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Using HPV vaccine for cervical cancer prevention: not an easy task
Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. :